Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
T-DM1-related telangiectasias: a potential role in secondary bleeding events.
Sibaud V, Vigarios E, Combemale P, Lamant L, Lacouture ME, Lacaze JL, Dalenc F, Delord JP. Sibaud V, et al. Among authors: lacaze jl. Ann Oncol. 2015 Feb;26(2):436-7. doi: 10.1093/annonc/mdu533. Epub 2014 Nov 17. Ann Oncol. 2015. PMID: 25403586 Free article. No abstract available.
PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy.
Jacot W, Dalenc F, Lopez-Crapez E, Chaltiel L, Durigova A, Gros N, Lozano N, Lacaze JL, Pouderoux S, Gladieff L, Romieu G, Roché H, Filleron T, Lamy PJ. Jacot W, et al. Among authors: lacaze jl. Breast Cancer Res Treat. 2019 Oct;177(3):659-667. doi: 10.1007/s10549-019-05349-y. Epub 2019 Jul 11. Breast Cancer Res Treat. 2019. PMID: 31297647
Diagnosis, biology and epidemiology of oligometastatic breast cancer.
Lacaze JL, Aziza R, Chira C, De Maio E, Izar F, Jouve E, Massabeau C, Pradines A, Selmes G, Ung M, Zerdoud S, Dalenc F. Lacaze JL, et al. Breast. 2021 Oct;59:144-156. doi: 10.1016/j.breast.2021.06.010. Epub 2021 Jul 1. Breast. 2021. PMID: 34252822 Free PMC article. Review.
Clinical and pathological characterization of 158 consecutive and unselected oligometastatic breast cancers in a single institution.
Lacaze JL, Chira C, Glemarec G, Monselet N, Cassou-Mounat T, De Maio E, Jouve E, Massabeau C, Brac de la Perrière C, Selmes G, Ung M, Nicolai V, Cabarrou B, Dalenc F. Lacaze JL, et al. Breast Cancer Res Treat. 2023 Apr;198(3):463-474. doi: 10.1007/s10549-023-06880-9. Epub 2023 Feb 15. Breast Cancer Res Treat. 2023. PMID: 36790573
Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care: A French regional multicenter study.
Pons-Tostivint E, Daubisse-Marliac L, Grosclaude P, Oum Sack E, Goddard J, Morel C, Dunet C, Sibrac L, Lagadic C, Bauvin E, Bergé Y, Bernard-Marty C, Vaysse C, Lacaze JLL; EvaSein Group. Pons-Tostivint E, et al. Among authors: lacaze jll. Breast. 2019 Aug;46:170-177. doi: 10.1016/j.breast.2019.06.001. Epub 2019 Jun 7. Breast. 2019. PMID: 31226572
Autoimmune bullous diseases induced by cyclin-dependent kinase 4/6 inhibitors-first cohort from the EADV Task Force 'Dermatology for Cancer Patients'.
Ortiz-Brugués A, Starace M, Bardazzi F, Koumaki D, Apalla Z, Iorizzo M, Bost C, Tournier E, Milesi S, Lacaze JL, Peris K, Sollena P, Sibaud V. Ortiz-Brugués A, et al. Among authors: lacaze jl. Ann Oncol. 2024 Oct;35(10):915-917. doi: 10.1016/j.annonc.2024.07.243. Ann Oncol. 2024. PMID: 39271254 No abstract available.
16 results